1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Clinical characteristics and pathologic diagnosis of the patients
Group/Patient No. Age (yr) Sex Histopathologic diagnosis SBO 1 66 M Chronic inflammation and fibrosis 2 41 F Active chronic inflammation and fibrosis 3 73 M Active chronic inflammation and fibrosis 4 63 M Active chronic inflammation and fibrosis 5 56 M Chronic inflammation and fibrosis 6 56 M Chronic inflammation and fibrosis 7 81 M Chronic inflammation and fibrosis 8 57 F Chronic inflammation and fibrosis 9 61 M Chronic inflammation, giant cell reaction, fibrosis NPC 1 47 M SCC, undifferentiated type 2 47 F SCC, undifferentiated type 3 44 M SCC, undifferentiated type 4 61 M SCC, undifferentiated type 5 60 M SCC, undifferentiated type 6 37 M SCC, moderately differentiated type 7 24 F SCC, undifferentiated type 8 62 M SCC, undifferentiated type 9 12 M SCC, undifferentiated type Lymphoma 1 14 M B-cell lymphoma 2 14 M B-cell lymphoma 3 14 M T-cell lymphoblastic-type lymphoma 4 43 F Diffuse large B-cell, immunoblastic type lymphoma 5 83 F Diffuse B-cell lymphoma 6 37 F Diffuse B-cell lymphoma 7 26 M T-cell lymphoblastic-type lymphoma 8 20 M B-cell lymphoma 9 49 M Diffuse large B-cell lymphoma Metastasis 1 60 M Undifferentiated carcinoma 2 53 M Undifferentiated carcinoma 3 58 M Prostate carcinoma 4 57 M Undifferentiated carcinoma 5 50 M Moderately differentiated carcinoma 6 54 F Multiple myeloma 7 46 M Multiple myeloma 8 48 M Multiple myeloma 9 71 M Prostate carcinoma